ePRONEProne Positioning in ARDS for Mortality Reduction
Daily prone position sessions
+ Prolonged prone position sessions
Lung Diseases+2
+ Respiration Disorders
+ Respiratory Distress Syndrome
Other Study
Summary
Study start date: April 7, 2025
Actual date on which the first participant was enrolled.This clinical trial focuses on patients suffering from Acute Respiratory Distress Syndrome (ARDS), which is a serious lung condition with a high risk of death. The study aims to determine if keeping patients in a prone position (lying face down) continuously for longer periods can reduce mortality compared to the standard practice of daily prone sessions. The prone position is known to improve lung function and reduce the harm caused by mechanical ventilation. This study is particularly important for patients who require mechanical breathing support and have severe ARDS, as finding the best prone position technique could improve survival rates. The trial involves two groups of patients, randomly assigned to either continuous or intermittent prone positioning. Those in the continuous group stay in the prone position for at least 48 hours, up to a maximum of 120 hours, while those in the intermittent group follow the current standard of 16 to 24 hours per day. This approach allows researchers to compare the effects on survival rates and any potential side effects of each method. The goal is to see which method helps keep oxygen levels stable and reduces the chances of complications over a period of seven days. The outcome of this study could lead to improved treatment strategies for those with severe ARDS.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.780 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 6 locations
Hospital Guillermo Grant Benavente
Concepción, ChileOpen Hospital Guillermo Grant Benavente in Google MapsComplejo Asistencial Dr. Victor Ríos Ruiz
Los Ángeles, ChileHospital de Quilpué
Quilpué, ChileClínica Las Condes
Santiago, Chile